ATE152113T1 - Vanadium komplexe, ihre herstellung und pharmazeutische zusammensetzungen, die sie enthalten - Google Patents

Vanadium komplexe, ihre herstellung und pharmazeutische zusammensetzungen, die sie enthalten

Info

Publication number
ATE152113T1
ATE152113T1 AT92401883T AT92401883T ATE152113T1 AT E152113 T1 ATE152113 T1 AT E152113T1 AT 92401883 T AT92401883 T AT 92401883T AT 92401883 T AT92401883 T AT 92401883T AT E152113 T1 ATE152113 T1 AT E152113T1
Authority
AT
Austria
Prior art keywords
alkyl
chemical structure
hydroxyl
formula
preparation
Prior art date
Application number
AT92401883T
Other languages
English (en)
Inventor
Jean-Michel Lacoste
Jacques Duhault
Denis Ravel
Original Assignee
Adir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adir filed Critical Adir
Application granted granted Critical
Publication of ATE152113T1 publication Critical patent/ATE152113T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/005—Compounds of elements of Group 5 of the Periodic Table without metal-carbon linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT92401883T 1991-07-03 1992-07-02 Vanadium komplexe, ihre herstellung und pharmazeutische zusammensetzungen, die sie enthalten ATE152113T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR919108253A FR2678622B1 (fr) 1991-07-03 1991-07-03 Nouveaux complexes de vanadium, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.

Publications (1)

Publication Number Publication Date
ATE152113T1 true ATE152113T1 (de) 1997-05-15

Family

ID=9414615

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92401883T ATE152113T1 (de) 1991-07-03 1992-07-02 Vanadium komplexe, ihre herstellung und pharmazeutische zusammensetzungen, die sie enthalten

Country Status (14)

Country Link
US (2) US5266565A (de)
EP (1) EP0521787B1 (de)
JP (1) JPH0742302B2 (de)
AT (1) ATE152113T1 (de)
AU (1) AU649849B2 (de)
CA (1) CA2072938A1 (de)
DE (1) DE69219221T2 (de)
DK (1) DK0521787T3 (de)
ES (1) ES2102478T3 (de)
FR (1) FR2678622B1 (de)
GR (1) GR3023940T3 (de)
IE (1) IE922160A1 (de)
NZ (1) NZ243418A (de)
ZA (1) ZA924966B (de)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5637739A (en) * 1990-03-21 1997-06-10 Research Corporation Technologies, Inc. Chiral catalysts and catalytic epoxidation catalyzed thereby
US6211107B1 (en) 1994-02-04 2001-04-03 Smithkline Beecham P.L.C. Process for expoxidizing prochiral olefins and a catalyst therefor and intermediates for making the catalyst
PL315786A1 (en) * 1994-02-04 1996-12-09 Smithkline Beecham Plc Method of epoxydising prochiral olefins, catalyst for use in this method and intermediate products for obtaining such catalyst
US20050053594A1 (en) * 1995-11-16 2005-03-10 Dario Alessi RAC-PK as a therapeutic agent or in diagnostics, screening method for agents and process for activating RAC-PK
US20020132326A1 (en) * 1995-12-15 2002-09-19 Hemmings Brian A. Process for activating a kinase
GB9525703D0 (en) * 1995-12-15 1996-02-14 Ciba Geigy Ag Screening method
US5955111A (en) * 1996-10-08 1999-09-21 Hartford Hospital Methods and compositions for inducing production of stress proteins
US5986136A (en) * 1997-04-15 1999-11-16 President And Fellows Of Harvard College Photolabeling reagent
AU7022198A (en) * 1997-04-24 1998-11-24 Angiotech Pharmaceuticals, Inc. Vanadium complexes and derivatives thereof and methods related thereto
US6232340B1 (en) 1997-04-24 2001-05-15 Angiotech Pharmaceuticals, Inc. Vanadium complexes and derivatives thereof and methods related thereto
US6043259A (en) * 1998-07-09 2000-03-28 Medicure Inc. Treatment of cardiovascular and related pathologies
WO2000024730A1 (en) * 1998-10-28 2000-05-04 The University Of British Columbia Organic vanadium(iii) complexes and their use
CA2366602A1 (en) 1999-03-08 2000-09-14 Medicure Inc. Pyridoxal analogues for vitamin b-6 disorders
RU2190618C2 (ru) * 1999-03-10 2002-10-10 Казанский государственный университет им. В.И.Ульянова-Ленина Новое комплексное соединение оксованадия (iv) с гидразидом изоникотиновой кислоты, обладающее антидиабетическим действием и проявляющее антимикобактериальную активность
CA2376029A1 (en) 1999-07-13 2001-01-18 Medicure Inc. Use of pyridoxin derivatives for the treatment of diabetes and related complications
US6677356B1 (en) * 1999-08-24 2004-01-13 Medicure International Inc. Treatment of cardiovascular and related pathologies
ITMI991894A1 (it) * 1999-09-09 2001-03-09 Carlo Ghisalberti Acido linoleico coniugato e trigliceride nuovi metodi di sintesi e d'uso
WO2001064692A1 (en) 2000-02-29 2001-09-07 Medicure International Inc. Cardioprotective phosphonates and malonates
US7442689B2 (en) * 2000-02-29 2008-10-28 Medicure International Inc. Cardioprotective phosphonates and malonates
CA2404329A1 (en) 2000-03-28 2001-10-04 Medicure International Inc. Treatment of cerebrovascular disease
NZ523815A (en) 2000-07-07 2004-07-30 Medicure Int Inc Pyridoxine and pyridoxal analogues: cardiovascular therapeutics
US6897228B2 (en) * 2000-07-07 2005-05-24 Medicure International Inc. Pyridoxine and pyridoxal analogues: new uses
US6548519B1 (en) 2001-07-06 2003-04-15 Medicure International Inc. Pyridoxine and pyridoxal analogues: novel uses
US20040121988A1 (en) * 2001-03-28 2004-06-24 Medicure International Inc. Treatment of cerebrovascular disease
US20040186077A1 (en) * 2003-03-17 2004-09-23 Medicure International Inc. Novel heteroaryl phosphonates as cardioprotective agents
US6957781B2 (en) * 2003-09-15 2005-10-25 Kraft Food Holdings, Inc. Cleaning attachment for fluid dispenser nozzles and fluid dispensers using same
JP2008505126A (ja) * 2004-07-07 2008-02-21 メディキュア インターナショナル インコーポレイテッド 血小板凝集薬を用いる併用療法
US20070060549A1 (en) * 2004-08-10 2007-03-15 Friesen Albert D Combination therapies employing ace inhibitors and uses thereof for the treatment of diabetic disorders
US7459468B2 (en) * 2004-10-28 2008-12-02 Medicure International, Inc. Aryl sulfonic pyridoxines as antiplatelet agents
US20060094749A1 (en) * 2004-10-28 2006-05-04 Medicure International Inc. Substituted pyridoxines as anti-platelet agents
EP1817288A4 (de) * 2004-10-28 2009-08-26 Medicure Int Inc Duale antiplättchen-/antikoagulans-pyridoxinanaloge
JP2009517411A (ja) * 2005-11-28 2009-04-30 メディキュア インターナショナル インコーポレーテッド 心血管及び関連病状の処置のための調剤
KR100722795B1 (ko) 2005-12-26 2007-05-30 한국조폐공사 초근적외선을 흡수하는 이소인돌린 비대칭 사량체환 화합물및 이를 이용한 제품
GB0607096D0 (en) * 2006-04-07 2006-05-17 Imp Innovations Ltd Compound
PL231079B1 (pl) 2012-11-07 2019-01-31 Univ Jagiellonski Kompleksy wanadu z hydrazydohydrazonami, preparaty farmaceutyczne oraz zastosowanie kompleksów wanadu z hydrazydohydrazonami
JP6735163B2 (ja) * 2016-06-22 2020-08-05 株式会社Adeka バナジウム化合物、薄膜形成用原料及び薄膜の製造方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2619382B1 (fr) * 1987-08-11 1990-05-04 Lazaro Rene Compose organo-mineral de vanadyle, procede d'obtention d'un tel compose, composition pharmaceutique contenant ce compose organo-mineral

Also Published As

Publication number Publication date
EP0521787A1 (de) 1993-01-07
JPH05186481A (ja) 1993-07-27
FR2678622B1 (fr) 1994-11-18
FR2678622A1 (fr) 1993-01-08
US5266565A (en) 1993-11-30
US5278154A (en) 1994-01-11
AU1941392A (en) 1993-01-07
DE69219221D1 (de) 1997-05-28
EP0521787B1 (de) 1997-04-23
DE69219221T2 (de) 1997-11-20
DK0521787T3 (da) 1997-10-27
NZ243418A (en) 1994-04-27
AU649849B2 (en) 1994-06-02
IE922160A1 (en) 1993-01-13
JPH0742302B2 (ja) 1995-05-10
ZA924966B (en) 1993-03-31
ES2102478T3 (es) 1997-08-01
GR3023940T3 (en) 1997-09-30
CA2072938A1 (fr) 1993-01-04

Similar Documents

Publication Publication Date Title
DE69219221D1 (de) Vanadium Komplexe, ihre Herstellung und pharmazeutische Zusammensetzungen, die sie enthalten
ES2149537T3 (es) Resina intercambiadora de aniones no reticulados y composicion farmaceutica que contiene la misma.
DK0434385T3 (da) Anvendelse af makrocycliske, nitroholdige forbindelser til behandling af retrovirale infektioner
DE69415445D1 (de) Zytotoxische Stilben-Derivate und diese enthaltende pharmazeutische Zusammensetzungen
ES8405398A1 (es) Procedimiento para preparar nuevos diazabiciclo-(3.3.1)-nonanos
ATE123769T1 (de) Inhibitoren von n-myristoyltransferase, deren verfahren zur herstellung und die sie enthaltenden pharmazeutischen zusammensetzungen.
DE69115768D1 (de) Chalkonderivate, Verfahren zu ihrer Herstellung und pharmazeutische Zusammensetzungen, die sie enthalten
DE69312984D1 (de) Substituierte Aminophosphonatderivate, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zusammensetzungen
DE69305276D1 (de) Arylglycinamidderivate, Verfahren zur deren Herstellung und deren Verwendung zur Therapie der Dysurie
ES2077070T3 (es) Intermedio de sintesis de 2-alquiniladenosina, produccion de dicho intermedio, produccion de 2-alquiniladenosina a partir de dicho intermedio, y derivado de 2-alquiniladenosina estable.
ATE111912T1 (de) Xanthinderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische präparate.
ATE135686T1 (de) Amphiphilische fluorierte schwefel-polyglycerol verbindungen, ihre enthaltende kosmetische oder pharmazeutische zusammensetzungen, verfahren zu ihrer herstellung und gestattende bläschen
ATE108440T1 (de) Arylaralkylether, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzung.
ATE125278T1 (de) Biologisch abbaubarer copolyester von 4- hydroxyprolin und diesen enthaltende pharmazeutische zusammensetzung.
ATE86993T1 (de) Heterotetracyclische laktamderivate, verfahren zu ihrer herstellung und pharmazeutische zubereitungen, die sie enthalten.
EA200300029A1 (ru) Новые соединения карбамат и тиокарбамат подофиллотоксина, способ их получения и содержащие их фармацевтические композиции
ES483247A1 (es) Procedimiento para la obtencion de nuevos diazacicloalquenostiosustituidos
ATE43594T1 (de) 3-alkoxy-2-(n-pyrrolidino)-n-pyridyl-n-furyl(od r thienyl)-methyl-propylamine, ihre herstellung und diese enthaltende pharmazeutische mittel.
IL100915A0 (en) Disubstituted ureas and thioureas,their preparation and pharmaceutical compositions containing them
FI903511A0 (fi) Pyrrolo (2,1-b) tiazolderivat.
HUT68636A (en) Benzopyrane derivatives, process for producing them, and pharmaceutical compositions containing them
DK460789A (da) 2-aminoacetamidderivater
TH9137A (th) สารประกอบเททราไซคลิคชนิดใหม่ซึ่งมีฤทธิ์ในการต่อต้านภูมิแพ้และต่อต้านโรคหืด การเตรียมและใช้สารเหล่านี้

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee